Active ingredient
Potassium Chloride
323 finished FDA listings contain Potassium Chloride as their only active ingredient; 300 combination products also contain it.
FDA NDC Directory
- Ingredient names as written by FDA
- POTASSIUM CHLORIDE
- Dosage forms
- Capsule, Capsule, Coated, Extended Release, Capsule, Extended Release, For Solution, Globule, Injection, Injection, Solution, Injection, Solution, Concentrate, Liquid, Pellet, Powder, For Solution, Solution, Spray, Tablet, Tablet, Chewable, Tablet, Extended Release, Tablet, Film Coated, Extended Release, Tablet, Soluble
- Routes
- Intravenous, Oral, Parenteral, Sublingual
- Manufacturers / labelers
- 93
- Strengths listed (first 60 of 68, A–Z)
- .75 g/.79g · 1 [hp_m]/[hp_m] · 1 [hp_m]/1 · 1 [hp_q]/1 · 1 [hp_x]/1 · 1 [hp_x]/ml · 1.125 g/1.185g · 1.5 g/1 · 1.5 g/1.54g · 1.5 g/1.56g · 1.5 g/1.57g · 1.5 g/1.58g · 1.5 g/1.77g · 1.5 g/15ml · 10 meq/1 · 10 meq/100ml · 10 meq/15ml · 10 meq/50ml · 100 [hp_c]/1 · 1125 mg/1 · 12 [hp_c]/1 · 12 [hp_c]/12[hp_c] · 12 [hp_x]/12[hp_x] · 14.9 g/1000ml · 14.9 g/100ml · 14.9 mg/ml · 149 mg/ml · 15 [hp_c]/15[hp_c] · 1500 mg/1 · 2 meq/ml · 20 meq/1 · 20 meq/100ml · 20 meq/15ml · 20 meq/30ml · 20 meq/50ml · 200 [hp_c]/1 · 200 [hp_c]/ml · 200 [kp_c]/200[kp_c] · 200 meq/1000ml · 29.8 g/1000ml · 29.8 mg/ml · 3 g/15ml · 3 g/3.16g · 3 g/30ml · 3 g/4.75g · 30 [hp_c]/1 · 30 [hp_c]/30[hp_c] · 30 [hp_x]/30[hp_x] · 40 meq/100ml · 40 meq/15ml · 40 meq/30ml · 400 meq/1000ml · 500 [hp_c]/1 · 6 [hp_c]/1 · 6 [hp_c]/6[hp_c] · 6 [hp_x]/1 · 6 [hp_x]/30ml · 6 [hp_x]/6[hp_x] · 6 [hp_x]/60mg · 6 [hp_x]/g
- Brand names in FDA listings
- Bestmade Natural Products Kali Mur, Bestmade Natural Products Kali Mur (Lactose-Free), Bestmade Natural Products Kali Mur 8x, Bm Kali Mur, Bm Kali Mur Icing Sugar, Bmnp Kali Mur, D-125, Kali Mur, Kali Muriaticum, Kali Muriaticum 6x, Kali Muriaticum Kit Refill, Kalium Muriaticum 6x, Klor-Con, Klor-Con M, Pokonza, Pokonza Potassium Chloride, Potassium Chloride, Potassium Chloride Extended Release, Potassium Chloride Extended-Release, Potassium Chloride For Oral Solution, Schuessler Tissue Salts Kali Mur Glandular Tonic 5
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 8591
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| ANDA 080205 | HOSPIRA | 1972-03-16 | 6 |
| NDA 019123 | UPSHER SMITH LABS | 1986-04-17 | 9 |
| NDA 019904 | BAXTER HLTHCARE | 1989-12-26 | 3 |
| NDA 020161 | OTSUKA ICU MEDCL | 1992-11-30 | 3 |
| ANDA 074726 | UPSHER SMITH LABS | 1998-11-20 | 14 |
| ANDA 075604 | ACTAVIS LABS FL INC | 2002-04-10 | 3 |
| ANDA 076368 | ADARE PHARMS INC | 2004-08-18 | 17 |
| ANDA 077419 | ACTAVIS LABS FL INC | 2008-06-02 | 2 |
| ANDA 202128 | AMNEAL PHARMS | 2013-02-22 | 3 |
| ANDA 204662 | PHARMOBEDIENT | 2014-08-21 | 3 |
| NDA 206814 | GENUS LIFESCIENCES | 2014-12-22 | 3 |
| NDA 208019 | GENUS | 2015-08-19 | 5 |
| ANDA 202868 | GLENMARK PHARMS LTD | 2016-01-19 | 3 |
| ANDA 203562 | GLENMARK PHARMS LTD | 2016-07-26 | 5 |
| ANDA 208864 | ADARE PHARMS INC | 2017-03-17 | 9 |
| ANDA 209688 | TWI PHARMS | 2018-01-12 | 7 |
| ANDA 209314 | YICHANG HUMANWELL | 2018-06-22 | 10 |
| ANDA 210041 | AMNEAL | 2018-07-19 | 5 |
| ANDA 210733 | STRIDES PHARMA | 2018-08-31 | 5 |
| ANDA 210921 | AUROBINDO PHARMA | 2018-12-19 | 12 |
| ANDA 210766 | PHARM ASSOC | 2019-03-29 | 6 |
| ANDA 209922 | PRINSTON INC | 2019-04-30 | 3 |
| ANDA 212183 | AJENAT PHARMS | 2019-05-06 | 5 |
| ANDA 212561 | YICHANG HUMANWELL | 2019-09-30 | 3 |
| ANDA 211797 | GRANULES | 2020-03-04 | 4 |
| ANDA 211087 | FRESENIUS KABI USA | 2020-09-09 | 5 |
| ANDA 210395 | ZYDUS PHARMS | 2020-09-17 | 4 |
| ANDA 214452 | GRANULES | 2020-10-21 | 21 |
| ANDA 214422 | ASCENT PHARMS INC | 2020-12-29 | 12 |
| ANDA 214686 | GRANULES | 2021-02-16 | 8 |
| ANDA 211667 | STRIDES PHARMA | 2021-03-11 | 4 |
| ANDA 214727 | NEXUS | 2021-03-18 | 3 |
| ANDA 214728 | AUROBINDO PHARMA LTD | 2021-03-31 | 3 |
| ANDA 211648 | SCIEGEN PHARMS | 2021-05-21 | 8 |
| ANDA 214076 | TRIS PHARMA INC | 2022-01-26 | 2 |
| ANDA 214108 | RUBICON RESEARCH | 2022-03-24 | 3 |
| ANDA 215725 | RUBICON RESEARCH | 2022-07-25 | 8 |
| ANDA 216156 | AJENAT PHARMS | 2023-03-07 | 4 |
| ANDA 216321 | RUBICON RESEARCH | 2023-06-16 | 3 |
| ANDA 218979 | TWI PHARMS | 2024-10-28 | 7 |
Showing 40 of 65 applications.
Official labeling on DailyMed
- POTASSIUM CHLORIDE EXTENDED-RELEASE TABLET, EXTENDED RELEASE [REMEDYREPACK INC.] · version 4 · 2026-09-10
- POTASSIUM CHLORIDE (POTASSIUM CHLORIDE ORAL) SOLUTION [CARDINAL HEALTH 107, LLC] · version 1 · 2026-09-02
- POTASSIUM CHLORIDE POWDER, FOR SOLUTION [CARDINAL HEALTH 107, LLC] · version 1 · 2026-09-02
- BMNP KALI MUR (KALIUM MURIATICUM) GLOBULE [TOTAL OPERATIONS MANAGEMENT LLC DBA:BESTMADE NATURAL PRODUCTS MICRO] · version 1 · 2026-09-02
- POTASSIUM CHLORIDE EXTENDED-RELEASE TABLET, EXTENDED RELEASE [REMEDYREPACK INC.] · version 6 · 2026-08-31
- POTASSIUM CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [COUPLER LLC] · version 1 · 2026-08-24
- POTASSIUM CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PREFERRED PHARMACEUTICALS INC.] · version 5 · 2026-08-19
- POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [STRIDES PHARMA SCIENCE LIMITED] · version 9 · 2026-08-18
- POTASSIUM CHLORIDE EXTENDED-RELEASE (POTASSIUM CHLORIDE) TABLET, EXTENDED RELEASE [REMEDYREPACK INC.] · version 6 · 2026-08-03
- POTASSIUM CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [REMEDYREPACK INC.] · version 13 · 2026-08-03
- POTASSIUM CHLORIDE FOR SOLUTION [AMNEAL PHARMACEUTICALS LLC] · version 3 · 2026-08-03
- POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [NORTHWIND HEALTH COMPANY, LLC] · version 1 · 2026-07-31
Showing the 12 most recent of 235 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.